Pro Medicus, Ltd. · ASX:PME

Pro Medicus — Shareholder Meeting (November 2009)

38 slides from Pro Medicus's shareholder meeting presentation, Nov 24, 2009

  1. Slide 1: Transformed and ready to go.... Annual General Meeting

    For personal use only Transformed and ready to go.... Annual General Meeting November 24th 2009 Australia’s Leading HealthCare IT Company

  2. Slide 2: Mel Ward - Chairman

    For personal use only PROMEDICUS • Mel Ward - Chairman

  3. Slide 3: Board Members

    Board Members For personal use only Mel Ward – Chairman David Chambers – CEO & Managing Director Sam Hupert – Deputy Chairman & Executive Director Anthony Hall – Executive Director Peter Jonson – Non-Executive Director Peter Kempen – Non-Executive Director

  4. Slide 4: Officers

    Officers For personal use only Danny Tauber – Chief Operating Officer Clayton Hatch – Finance Manager - Company Secretary Stuart Painter – Ernst and Young Auditor In absentia: Malte Westerhoff – Chief Technology Officer (Visage - Germany) Mike Tefft – National Business Manager (Visage - USA)

  5. Slide 5: Pro Medicus – In Perspective

    Pro Medicus – In Perspective For personal use only 4 • 2007/08 –Sustained profit growth and optimism re acquisition opportunity. • 2008/09 – A time of change facing the global financial crisis, a major acquisition, and changes with overseas partner. • 2009/10 – A time of transition to a challenging

  6. Slide 6: Pro Medicus – 2007/08

    Pro Medicus – 2007/08 For personal use only • What were our messages last year? • World wide GFC started --- fear of recession • Mature Australian market --- need to go off-shore • US key to our future growth • New AGFA agreement but standalone PME in US • Search on for complementary acquisition • E

  7. Slide 7: 2008/09 – A Tough Year of Change

    2008/09 – A Tough Year of Change For personal use only • GFC – Dramatic impact on last 3 quarters of year • Downturn of health IT spending in US • Contraction in Aust market due to: - GFC effect - Maturity of digital market - Increased competition with aggressive prices • Costs of establishing stand

  8. Slide 8: Pro Medicus – 2008/09 Highlights

    Pro Medicus – 2008/09 Highlights For personal use only 7 • Revenue, including acquisition, up 1.4% to $15.62M • NPAT down 28.4% to $5.68M • First time since listing that profit has fallen • Acquisition of Visage is transformational • Acquisition funded from cash • Balance Sheet still strong – no deb

  9. Slide 9: Pro Medicus – 2008/09 Highlights

    Pro Medicus – 2008/09 Highlights For personal use only • Final dividend of 2c per share fully franked following interim dividend of 1.5c • Significant reduction of net margin from acquisition and effect of competition in both US and Australia • Service revenues and Promedicus.net revenue held up wel

  10. Slide 10: Pro Medicus – Visage Imaging

    Pro Medicus – Visage Imaging For personal use only • The long search for a complementary off-shore partner has been reported for some years • Cash was held in reserve for this purpose • The right partner was found in late 2008 in Visage Imaging • GFC downturn in asset prices assisted buy • CEO will

  11. Slide 11: Promedicus – Visage

    Promedicus – Visage For personal use only 10 • Visage was initially loss making (PME funding) but back to break even • Growing revenue from sales in all three markets • Other revenue streams from Visage (OEM, Amira) are profitable • We trade as Visage Imaging in North America and Europe to gain bran

  12. Slide 12: Pro Medicus – PME/Visage Integration

    Pro Medicus – PME/Visage Integration For personal use only • Visage is Berlin based and has a very strong R&D capability. • Integration of R&D: Melbourne PME team with Berlin Visage team, going well with full alignment on product strategy • PME Melbourne objective of having a totally modernized RIS

  13. Slide 13: Pro Medicus – Key Issues

    Pro Medicus – Key Issues For personal use only 12 • Successfully complete integrated product development to the 2010 schedule • Extend upon brand recognition and make optimal impact at RSNA (November 2009) • Well balanced R&D teams in Melb and Berlin, • Must accelerate sales and marketing skills • O

  14. Slide 14: Looking Forward --- 2009/10

    Looking Forward --- 2009/10 For personal use only • This is a major transition year • World wide there are still volatile and uncertain conditions • Share markets are still far below their pre-crisis levels • With PME and Visage combined products we have achieved some key reference sites already in

  15. Slide 15: 2009/10 Outlook

    2009/10 Outlook For personal use only • Continuing investment in product development and integration • Continued investment in sales team development in US and Australia • A slow start in 1st Quarter but momentum expected to build into the 2nd half • Profit outcome expected to be approximately the s

  16. Slide 16: Pro Medicus -- Final Comments

    Pro Medicus -- Final Comments For personal use only 15 • Continue to move to refresh Board for the future • My thanks to Directors for their strong contribution • Welcome to our new European and North American staff who have joined the PME family • Thanks to our management and staff for their innova

  17. Slide 17: David Chambers – CEO & Managing Director

    For personal use only PROMEDICUS • David Chambers – CEO & Managing Director

  18. Slide 18: The 'new' Promedicus

    The ‘new’ Promedicus …evolution of a global strategy For personal use only 17 M&A R&D Amira Visage 3D RIS/PMS E:Health 2D/3D/4D RIS Ver 7 .net Life Sciences Healthcare 3D tools Visage 7 PACS/RIS/3D .net/portals • Acquisition of Visage Imaging (January 2009) • A comprehensive Healthcare and Life Scie

  19. Slide 19: Visage Imaging®

    Visage Imaging® So who is Visage Imaging? For personal use only • Clinical Imaging Products: 3D Advanced Visualization software • Visualization Products for other Life Sciences: Amira® • Direct Sales and OEM Business

  20. Slide 20: Opportunity to bring together all the pieces

    Opportunity to bring together all the pieces for a best practice end to end solution For personal use only 19 2D RIS/PMS PACS Visage provide the PACS (2D) and 3D PME provide the RIS 3D/4D advanced (Practice Management) visualisation software & E:Health E:Health In combination, we have developed the

  21. Slide 21: Technology Synergies

    Technology Synergies For personal use only • Integration of two products (RIS/PACS) realizes vision of becoming true single vendor solution . • New products and development skills in Berlin • Expand the reach of information through use of ‘thin client’ • Move ahead of technology wave from 2D to 3D/4

  22. Slide 22: Business Synergies

    Business Synergies For personal use only • Expanded installed base and local understanding of markets (e.g. US, Europe) provides basis for growth • Up-selling opportunities for local Australian business • Expand target audience to public hospitals • Added and different channel models e.g. OEM’s, web

  23. Slide 23: Pro Medicus, now truly global…

    Pro Medicus, now truly global… For personal use only A Full Suite of Enterprise PACS/RIS/Visualization and E:Health Business Software Solutions • 70 employees, in four centers (US, Germany and Australia) • ISO 9001 + 13485 certified, FDA/CE/CAMCAS cleared medical products • Turnover ~A$23M, Market C

  24. Slide 24: Synergies create a Global Strategy

    Synergies create a Global Strategy For personal use only 3D ‘PACS/RIS’ Appliance Visage 7 Sales Visage 7 Enterprise PACS PME OEM’s RIS/PMS E:Health Amira

  25. Slide 25: Major Highlights 2008/2009

    Major Highlights 2008/2009 For personal use only • Acquisition in January 2009 • Visage integration has been very successful • Sales momentum is increasing in US and Europe. • Several deals e.g. Hamburg, Connecticut in 1st six months • Attended several major conferences with positive feedback e.g. U

  26. Slide 26: Medical Imaging Market

    Medical Imaging Market Data explosion poses big challenges to radiology For personal use only • Typical CT Exam: • 1995 – 20 Images per CT Exam • 2000 – 100 Images per CT Exam • 2009 – 2,000 Images per CT Exam

  27. Slide 27: How 'Thin Client' Make Life Easier

    How ‘Thin Client’ Make Life Easier For personal use only • Images do not move from where they are generated – incredibly network efficient • Access to images, and use of all the tools when/where they are needed, irrespective of location, image size or complexity – Flexibility to work from home or of

  28. Slide 28: The Lake Imaging Solution

    The Lake Imaging Solution Combines all Promedicus products For personal use only Ordering Order Entry Scheduling Decision Support Patient arrival Business Intelligence RIS/PACS/3D Reporting Acquisition Billing Integrated workflow 2D/3D/4D + Advanced Clinical Applications Notification & Distribution

  29. Slide 29: RSNA Ad Campaign – Visage

    RSNA Ad Campaign – Visage 7 For personal use only Now Apple MAC Compatible

  30. Slide 30: Visage 7…True Versatility.True Performance

    Visage 7…True Versatility.True Performance For personal use only 29 • Visage 7 ‘unified viewer’ using thin client technology allows Radiologists to see images anywhere, in the fastest possible time • Can be an Enterprise Viewer or incorporated in to end to end imaging centre solution (like Lake Imag

  31. Slide 31: Quotes from our recent clients…

    Quotes from our recent clients… For personal use only 30 Enterprise Viewer Setting (in Hospital) Distributed Viewer Setting (in Imaging Centre) “There are 3 important requirements that I “We wanted to step up to a 4th generation consider when evaluating an enterprise PACS and after an exhaustive sea

  32. Slide 32: Amira - Smart Imaging in Life Sciences

    Amira - Smart Imaging in Life Sciences making sense of large volume data sets For personal use only Volumetric Analyis Blood Flow Numerical Simulation Anatomic Modelling Drug Development / Molecular Virtual Reality Images: amira®

  33. Slide 33: Investment in Future

    Investment in Future For personal use only • Investments in R&D bearing fruit with milestones met for new technology platform. • Ongoing investment in new people and infrastructure. • Underpins future by transitioning products to new technology platform. • Increasing our presence and skills in North

  34. Slide 34: We believe we have the right growth strategies for 2010

    We believe we have the right growth strategies for 2010 For personal use only 33 US and European New sales expansion channels Expanded Visage Imaging – product portfolio Promedicus continuing integration New (RIS) Penetrate technology platform hospital market

  35. Slide 35: PROMEDICUS

    For personal use only PROMEDICUS

  36. Slide 36: Resolution – Adopt the Remuneration Report

    RESOLUTION OF SHAREHOLDERS For personal use only • Resolution 2 – To adopt the Remuneration Report (non binding) FOR OPEN AGAINST 21,881,759 346,312 339,967 96.96% 1.53% 1.51%

  37. Slide 37: Resolution 3A – Elect Director Dr Sam Hupert

    RESOLUTION OF SHAREHOLDERS For personal use only • Resolution 3A – To elect as a Director Dr Sam Hupert FOR OPEN AGAINST 22,140,011 415,212 19,000 98.08% 1.84% 0.08%

  38. Slide 38: Resolution 3B – Elect Director Mr Melvyn Ward

    RESOLUTION OF SHAREHOLDERS For personal use only • Resolution 3B – To elect as a Director Mr Melvyn Ward FOR OPEN AGAINST 22,134,697 415,212 44,314 97.97% 1.84% 0.20%

Pro Medicus — Shareholder Meeting (November 2009) on 6ix